What is Trevi Therapeutics, Inc.'s free cash flow yield?

Trevi Therapeutics, Inc. (TRVI) reported free cash flow yield of -23.9% in Q4 2023.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Trevi Therapeutics, Inc. TRVI Free cash flow yield

Free cash flow yield at other companies

Merck & Co.MRK

4.7%-2.8pp

SavaraSVRA

-9.6%-3.3pp

Indivior Pharmaceuticals, Inc. INDV

-5.2%—

Theravance BiopharmaTBPH

25.2%+23.0pp

LQD

Liquidia CorporationLQDA

-5.3%-1.9pp

United TherapeuticsUTHR

3.9%-4.2pp

Other financials

Income statement

See full

Operating income-$14.9M-30.0%

Net income-$13.2M-27.6%

EPS (diluted)-$0.090.0%

Balance sheet

See full

Cash & equivalents$19.4M+0.2%

Total debt$682.0K-28.7%

Total equity$172.1M+73.1%

Total assets$179.6M+67.8%

Cash flow

See full

Operating cash flow-$16.7M-23.8%

CapEx$102.0K—

Free cash flow-$16.8M—

Valuation

See full

Market cap$2.49B+252%

Enterprise value$2.47B+259%

Returns & leverage

See full

Return on equity-33.6%-9.4pp

Debt / equity0×0.0×

Current ratio24.8×+9.4×

Where this comes from

Calculated from Trevi Therapeutics, Inc.’s reported figures.

free cash flow/market cap=-23.9%

Based on trailing twelve months.

The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s free cash flow yield?: Trevi Therapeutics, Inc. (TRVI) reported free cash flow yield of -23.9% in Q4 2023.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.